Salix Pharmaceuticals, Ltd.

549300IIP8FMEZXA0183

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: December 31, 2001

Address

Country: United States
Legal address: C/O UNITED AGENT GROUP INC., 1521 CONCORD PIKE SUITE 20119803 WILMINGTONUnited States (US-DE)
Head office: 8510 Colonnade Center Drive27615 RaleighUnited States (US-NC)

Identifier

LEI: 549300IIP8FMEZXA0183
Registered: December 20, 2013 at 03:00 AM UTC
Last updated: September 3, 2026 at 09:01 PM UTC
Next renewal: December 16, 2014 at 11:00 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 3473908
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 3473908
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The parent is one or more private individuals

Machine access

REST: https://lei.online/v1/entities/549300IIP8FMEZXA0183This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search